Results 181 to 190 of about 10,985 (213)

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use

Drug Resistance Updates, 2006
María P. Sánchez-Cañete, Simon L Croft, Shyam Sundar   +2 more
exaly  

Oral Miltefosine for Indian Visceral Leishmaniasis

New England Journal of Medicine, 2002
Shyam Sundar
exaly  

Ketoconazole/miltefosine

Reactions Weekly, 2021
openaire   +1 more source

Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis

New England Journal of Medicine, 1999
Shyam Sundar, Juntra Karbwang
exaly  

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis

EBioMedicine, 2018
Juliana B T Carnielli, Kathryn Crouch, Sarah Forrester   +2 more
exaly  

Ibrutinib/miltefosine

Reactions Weekly, 2022
openaire   +1 more source

Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo

International Journal of Antimicrobial Agents, 2007
Karin Seifert, María P. Sánchez-Cañete, Santiago Castanys   +2 more
exaly  

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)

International Journal of Antimicrobial Agents, 2003
Karin Seifert, Santiago Castanys, Francisco Gamarro   +2 more
exaly  

Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: A proof of mechanism for trypanosomatid chemotherapy

Journal of Controlled Release, 2012
Beatriz G De La Torre, Valentin Hornillos, Jean-Mathieu Bart   +2 more
exaly  

Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment

Materials Science and Engineering C, 2017
Mónica C García, Valker Araujo Feitosa, Daniela S Bassères   +2 more
exaly